- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2018
- Public Summary Document (PSD) March 2018 PBAC Meeting - PDF
- Public Summary Document (PSD) March 2018 PBAC Meeting - Word
Lenalidomide – March 2018
Lenalidomide: Capsule, 5 mg, 10 mg and 15 mg; Revlimid®
Last updated
13 July 2018